{"version":"1.0","type":"link","title":"Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.","author_name":"Curigliano G 외","author_url":"https://prs-insight.online/author/Curigliano%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/77980","thumbnail_width":1200,"thumbnail_height":630}